New blood test could catch bile duct Cancer's return sooner
NCT ID NCT06474091
Summary
This study is testing whether a new type of blood test can help doctors monitor patients with bile duct cancer (cholangiocarcinoma) after surgery. Researchers will check if specific markers in the blood can predict if the cancer is likely to come back or progress. The goal is to see if this 'liquid biopsy' can provide an early warning sign, allowing for quicker intervention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.